Stay Up to Date
with SHINE

The University of Wisconsin-Madison College of Engineering has awarded Dr. Greg Piefer, founder and CEO of SHINE Medical Technologies, Inc. (SHINE) the Early-Career Achievement Award.

Successful generation of Tc-99m is a supply chain advancement that can help ensure patient access to critical medical imaging scans.

Nuclear Regulatory Commission (NRC), has completed their safety and environmental reviews and recommends approval of a Construction Permit for the SHINE facility

SHINE Medical Technologies, Inc. (SHINE) has been awarded $1 million from the U.S. Department of Energy’s National Nuclear Security Administration (DOE/NNSA) as part of a $2 million cooperative agreement.

SHINE announced today that it has been awarded $150,000 from the National Science Foundation for Phase I of an SBIR (Small Business Innovation Research) Grant.

Argonne National Laboratory and SHINE announced today that Argonne successfully demonstrated the production, separation and purification of molybdenum-99 (Mo-99) from SHINE’s innovative liquid target.

SHINE announced today that the Company’s primary regulator, the Nuclear Regulatory Commission (NRC), has released for public review and comment the draft Environmental Impact Statement (EIS) for the SHINE medical isotope production facility in Janesville, WI.

Lantheus and SHINE announced that the companies have entered into a strategic agreement for the future supply of molybdenum-99 (Mo-99).

SHINE Medical Technologies and Phoenix Nuclear Labs announced today that they successfully operated their second-generation neutron driver prototype for 24 consecutive hours with 99% uptime.

SHINE Medical Technologies, Inc. announced today that the Nuclear Regulatory Commission (NRC) has accepted for review the second half of SHINE’s construction permit application to build a medical isotope production plant near Janesville, WI.

SHINE updates the Janesville Community.

SHINE has submitted the remaining chapters of its Construction Permit application to the Nuclear Regulatory Commission (NRC).

SHINE has received notice that the Nuclear Regulatory Commission (NRC) has accepted the first part of its Construction Permit application for review and docketing.

Today, Los Alamos National Laboratory announced that for the first time, irradiated low-enriched uranium (LEU) fuel has been recycled and reused for molybdenum-99 (Mo-99) production, with virtually no losses in Mo-99 yields or uranium recovery.

SHINE Medical Technologies announced today that its development program with Phoenix Nuclear Labs (PNL) reached an important technical milestone by successfully producing 3×1011 neutrons per second with the deuterium-deuterium fusion reaction.